Patents by Inventor Rachel SOON

Rachel SOON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL REGIMES OF FXR AGONISTS
    Publication number: 20210283105
    Abstract: The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 16, 2021
    Inventors: Michael BADMAN, Andreas BAUER, Jin CHEN, Bryan LAFFITTE, Patrick MUELLER, Rachel SOON
  • Regimes of FXR agonists
    Patent number: 11052069
    Abstract: The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: July 6, 2021
    Assignee: Novartis AG
    Inventors: Bryan Laffitte, Andreas Bauer, Michael Badman, Jin Chen, Patrick Mueller, Rachel Soon
  • NOVEL REGIMES OF FXR AGONISTS
    Publication number: 20190262313
    Abstract: The invention provides novel regimens of farnesoid X receptor (FXR) agonist and methods for modulating the activity of farnesoid X receptors (FXRs) using novel regimes of specific FXR agonists, in particular for treating or preventing fibrotic or cirrhotic diseases or disorders, such as liver diseases.
    Type: Application
    Filed: September 12, 2017
    Publication date: August 29, 2019
    Inventors: Bryan LAFFITTE, Andreas BAUER, Michael BADMAN, Jin CHEN, Patrick MUELLER, Rachel SOON